Delia buys ALNY 53.71: Alnylam to Webcast Conference Call Discussing Second Quarter 2014 Financial Results
CAMBRIDGE, Mass., Jul 31, 2014 (BUSINESS WIRE) -- Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) , a leading RNAi therapeutics company, today announced that it will report financial results for the second quarter ending June 30, 2014 on Thursday, August 7 ... ...
56 people liked this
0 Comments:
Post a Comment
Subscribe to Post Comments [Atom]
<< Home